A transgenic C57BL/6 mouse, expressing the hACE2 gene under the control of the mouse Ace2 promoter, was first developed as a model system to study severe acute respiratory syndrome (SARS) caused by SARS-CoV [2]. This evidence concerns the gene ACE2 and severe acute respiratory syndrome.